Santarus Inc (SNTS)

[deniseann]

Santarus to Webcast Analyst Day and Investor Briefing Presentation on January 19

PR Newswire
SAN DIEGO, Jan. 19, 2011
SAN DIEGO, Jan. 19, 2011 /PRNewswire/ -- Santarus, Inc. (Nasdaq: SNTS) announces that a live audio webcast and accompanying slide presentation will be provided for its Analyst Day and Investor Briefing.
Details of the event are as follows:
What: Santarus Analyst Day and Investor Briefing

When: Today, Wednesday, January 19, 2011 at 4:15 p.m. Eastern time

Where: www.santarus.com (under the Investor Relations link)


AGENDA
• Strategic Overview and 2011 Financial Outlook
Gerald T. Proehl, President, Chief Executive Officer & Director, Santarus, Inc.
• CYCLOSET® - Clinical/Medical Background
Dr. J. Michael Gaziano, Chief, Division of Aging, Brigham & Women’s Hospital,
Professor of Medicine, Harvard Medical School
• ULTESA™ (Budesonide MMX®) – Overview and Top-line Phase III Clinical Study Results
Dr. Simon P.L. Travis, Consultant Gastroenterologist,
Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK
• Ulcerative Colitis – Treatment Perspective
Dr. William J. Sandborn, Professor of Clinical Medicine and Chief of the Division of Gastroenterology, University of California, San Diego
• RHUCIN® and Hereditary Angioedema (HAE)
Dr. Bruce L. Zuraw, Professor of Medicine and Chief, Allergy and Immunology, University of California, San Diego, Research Scientist, San Diego VA Healthcare
• SAN-300 (anti-VLA-1 antibody)
Dr. Mark C. Totoritis, Senior Vice President, Biologics, Santarus, Inc.
• Wrap-up/Question & Answer Session
Gerald T. Proehl, President, Chief Executive Officer & Director, Santarus, Inc.
How: Live over the Internet – Simply log on to the Investor Relations section of the company's website at www.santarus.com


Contact:


Lippert/Heilshorn & Associates
Narine Darbinyan
310-691-7100